{"url":"https://lda.gov/api/v1/filings/ed3d3fe1-ac4f-4613-9365-db99220f53f7/","filing_uuid":"ed3d3fe1-ac4f-4613-9365-db99220f53f7","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/ed3d3fe1-ac4f-4613-9365-db99220f53f7/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"S. Bradley Traverse","dt_posted":"2025-04-21T18:43:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"440 1st Street, NW","registrant_address_2":"Suite 430","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401105750,"url":"https://lda.gov/api/v1/registrants/401105750/","house_registrant_id":null,"name":"INFUSION PROVIDERS ALLIANCE","description":"Healthcare Association","address_1":"610 10th St. NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELLIOTT WARREN","contact_telephone":"+1 202-557-8983","dt_updated":"2026-07-20T10:21:59.863856-04:00"},"client":{"id":212363,"url":"https://lda.gov/api/v1/clients/212363/","client_id":12,"name":"INFUSION PROVIDERS ALLIANCE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-31"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":111972,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"TRAVERSE","suffix":null,"suffix_display":null},"covered_position":"Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":111972,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"TRAVERSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}